BOULDER, Colo., Jan. 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, February 3, 2015. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.



    Date:                            Tuesday, February 3, 2015

    Time:                            9:00 a.m. Eastern Time

    Toll-Free:                       (844) 464-3927

    Toll:                            (765) 507-2598

    Pass Code:                                                    64812242

    Webcast, including Replay and Conference Call Slides: http://
     edge.media-server.com/m/p/s2coayon/lan/en

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.



    CONTACT:                          Tricia Haugeto

                                      Array BioPharma Inc.

                                      (303) 386-1193

                                      thaugeto@arraybiopharma.com

http://photos.prnewswire.com/prnvar/20121029/LA02195LOGO

Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-report-financial-results-for-the-second-quarter-of-fiscal-2015-on-february-3-2015-300025684.html

SOURCE Array BioPharma Inc.